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To have sepsis or to be septic—is the difference between these clinical
conditions important?
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idThe past three decades has seen various controversies over
deﬁnitions and approaches to managing the patient with sepsis.
The recent proposal for a new deﬁnition of ‘sepsis’ arising from the
Third International Consensus Deﬁnitions for Sepsis and Septic
Shock (Sepsis-3)1 has created further confusion, and a lively debate
has followed its publication, with calls for a re-assessment of
the deﬁnitions.2–4 The key point of confusion seems to be that the
clinical condition referred to as ‘sepsis’ is being confused with
the patient ‘being septic’.
Accurate deﬁnition of a disease entity should help facilitate
immediate clinical action through instituting relevant diagnostic
procedures and appropriate management. The recent proposal of
sepsis does not do that,1 because a septic patient may be ill due to a
range of other infections such as severe malaria, inﬂuenza, or Ebola
virus disease, and will still be labelled as having sepsis. The new
deﬁnition, or should we call it the ‘so-called deﬁnition’, is based on
a set of organ-speciﬁc predictors of outcome and is not a deﬁnition
of a clinical entity that could usefully help the clinician to manage
septic patients rationally.
‘Sepsis’, to the infectious disease physician, is an illness caused
by the presence of bacteria in the body tissues or bloodstream, i.e.,
an ill patient for whom blood culture is positive or is expected to be
positive. Thus the word ‘sepsis’ immediately informs the physician
that here is someone with a potentially life-threatening bacterial
infection that requires treatment with appropriate antibiotic
cover, and that the identiﬁcation of the focus or source of the
bacterial infection via appropriate investigations, including
microbiological and imaging diagnostic procedures, may be
required.
‘Septic’ is a very different term from ‘sepsis’ to the infectious
disease physician; the patient being septic means that the patient
has the same symptomatology as a patient with sepsis, but the
bacterial diagnosis may not be obvious and a range of other
pathogens need to be considered much more broadly, so that
appropriate, pathogen-speciﬁc therapy can be instituted. For
instance, a patient with severe inﬂuenza, malaria, or viral
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).haemorrhagic fever may be septic on presentation, but does not
have sepsis as per the deﬁnition.
The initial deﬁnition of sepsis from 1992 deﬁned sepsis as ‘‘a
clinical response arising from infection’’ without clearly deﬁning
‘infection’ (whether it meant bacterial, viral, fungal, or parasitic) as
the underlying cause.5 The paper then introduced the concept of
‘systemic inﬂammatory response syndrome’ (SIRS), to include non-
infectious clinical conditions that show a sepsis-like presentation.
The authors argued that it is likely that a common pathophysiology
underlies SIRS, and that this justiﬁed the use of the term ‘SIRS’ no
matter what the underlying aetiology. Now, 25 years later, we
question this key assumption behind the introduction of the ‘SIRS’
concept. The paper also deﬁned sepsis, severe sepsis, and septic
shock, and it is obvious that the authors were focused on bacterial
infections throughout – and not viral, fungal, parasitic, or other
non-infectious causes.
The next major attempt to revise the deﬁnitions of sepsis was in
2001.6 This paper discussed the possibility of deﬁning sepsis based
on biochemical parameters alone. It was stated that sepsis is ‘‘a
pathologic process caused by the invasion of normally sterile tissue
or ﬂuid or body cavity by pathogenic or potentially pathogenic
microorganisms’’. The paper concluded that ‘‘the current concepts
of sepsis, severe sepsis, and septic shock seem to be robust
deﬁnitions and should remain as described 10 years ago’’. The
major difference between the 1992 and 2001 deﬁnitions is the
detailed listing of biochemical markers for use in patients with
sepsis. The deﬁnition did not speciﬁcally distinguish between viral,
parasitic, and other causes, and yet again the authors must have
primarily been thinking of invasive bacterial infection.
The recent attempt to deﬁne sepsis has focused on organ
dysfunction.1 In this paper, sepsis is deﬁned as ‘‘life-threatening
organ dysfunction caused by a dysregulated host response to
infection’’. The deﬁnition does not distinguish between bacterial,
viral, and parasitic infections, and it is suggested that the concept
of ‘severe sepsis’ be abandoned. Furthermore, a detailed scoring
system with ﬁve levels for dysfunction of respiration, coagulation,
liver, cardiovascular, central nervous system, and renal functions is
introduced (see Table 1 in Singer et al.1). The scoring system
predicts severity and thus outcome and is useful when performing
studies where it is important that the patient meets certain
inclusion criteria and important when comparing outcomes
between different units.
But is a scoring system predicting outcome a deﬁnition of a
clinical entity? Certainly the proposed scoring system improvesociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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condition, but it does not help the physician in planning a rational
strategy for management, because it entirely ignores the speciﬁc
microbial (bacterial, viral, fungal, or parasitic) or non-microbial
aetiology of the condition. Thus it does not help map out a rational
management strategy (speciﬁc choice of antibiotics, antimalarial,
antivirals, steroids) and does not discuss the appropriate
diagnostic tests to be used in a patient with ‘sepsis’.
In all three deﬁnitions (the 1992, 2001, and 2016 deﬁnitions) it
is stressed that common deﬁnitions and criteria are needed in
order to perform comparable research studies on well-deﬁned
patient populations. This is critical, but existing deﬁnitions of
‘sepsis’ and ‘being septic’ will challenge a scoring system for
predicting outcomes that allows patients with bacterial blood
stream infections, malaria, and inﬂuenza to be pooled. Studies will
need to include patients with a common microbial aetiology to be
comparable and rational.
It is important that we return to the 1992 deﬁnition and deﬁne
‘sepsis’ as a response to bacterial infection, and that we consider
other microbial aetiologies when using the term ‘septic’. This will
help the attending clinician to think more broadly and to work out
the most appropriate management strategy based on consider-
ations of probabilities for different diagnoses.
The deﬁnition of sepsis presented by the Third International
Consensus Deﬁnitions for Sepsis and Septic Shock (Sepsis-3)1
fulﬁls the criteria for US hospitals to bill the insurance system for a
patient with ‘sepsis’ and also satisﬁes the US health care system
requirement for a single diagnosis to classify patients with fever
and organ dysfunction. However, the confusion and debate it has
created requires global consensus to be obtained in deﬁning
‘sepsis’ and ‘septic’ so that the deﬁnitions are universally
acceptable. For low- and middle-income countries where there
are limited resources for intensive investigations, a new paradigm
should include practical guidelines with management algorithms,
so that all speciﬁc aetiologies of the septic patient can be
considered and treated. This will also assist in achieving common
research protocols.Conﬂict of interest: None.
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